NCT06030440
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
- Locations
-
- Universitätsklinikum Erlangen, Strahlenklinik Erlangen, Bavaria, Germany
Clinical trial condition
Squamous Cell Carcinoma of the Oral Cavity
Explore clinical trials studying Squamous Cell Carcinoma of the Oral Cavity. Study availability and eligibility vary by location and protocol.
17 public trials
3 recruiting studies
Squamous Cell Carcinoma of the Oral Cavity trial results
NCT04191460
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +11 more
- Locations
-
- Erasmus University Medical Center Rotterdam, South Holland, Netherlands
NCT06380686
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
- Locations
-
- Universitätsklinikum Essen Essen, Germany
- Onkologie/Studienzentrum am Raschplatz GbR Hanover, Germany
Not yet recruiting
CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC
NCT06609070
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
- Locations
-
Not specified
Active, not recruiting
Contribution of Residual Tumour DNA Testing on the Surgical Bed
NCT05934929
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- CHU Rouen Rouen, France
- Centre Henri Becquerel Rouen, France
Active, not recruiting
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
NCT05540899
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +10 more
- Locations
-
- Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
Completed
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03370276
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma, +14 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University School of Medicine Atlanta, Georgia, United States
- The Ohio State University Columbus, Ohio, United States
Completed
CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
NCT03721757
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- Clatterbridge Cancer Centre NHS Foundation Trust Bebington, United Kingdom
NCT03459729
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT02609386
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Banner University Medical Center Tucson, Arizona, United States
- University of Arkansas For Medical Sciences Little Rock, Arkansas, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Stanford University Medical Center Stanford, California, United States